EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prediction of Postoperative Intravesical Recurrence Using Urine DNA Monitoring in Nonmuscular‐Invasive Urothelial Bladder Cancer

Masashi Shiozaki iD, Tomonori Minagawa iD, Hitoshi Yokoyama, Yosuke Hirotsu iD, Toshio Oyama, Masao Omata iD, Yoshiyuki Akiyama iD

International Journal of Urology · 2026

DOI: 10.1111/iju.70293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, 2026. Verfasst von Masashi Shiozaki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shinshu University School of Medicine, Nagano, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Neoplasm Recurrence, Local, Carcinoma, Transitional Cell, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by a Grant-in-Aid for the Genome Research Project from Yamanashi Prefecture (to M.O. and Y.H.), the Japan Society for the Promotion of….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Considering the high frequency of intravesical recurrence in bladder urothelial carcinoma (UBC), accurate non‐invasive biomarkers for recurrence prediction are needed for better management after transurethral surgery. This pilot study examined the usefulness of urine DNA for detecting and predicting intravesical recurrence in UBC.

Methods

Patients with primary nonmuscle‐invasive UBC were prospectively enrolled just after initial transurethral surgery. Genomic profiles were evaluated in resected specimens of the original tumor and in urine during follow‐up. Urine DNA, urine cytology, and cystoscopy were all evaluated at 3‐month intervals until 1 year postoperatively. Upon centrifuging urine samples into precipitation and supernatant fractions, we retrospectively evaluated urine DNA using a genomic panel established in our previous report.

Results

In the 19 patients enrolled, intravesical recurrent tumors were detected in six patients by cystoscopy. Urine DNA was positive in all of the recurrence cases before or at the time of cystoscopic or cytological detection, whereas urine cytology did not test positive before cystoscopic recurrence. Both urine precipitation and supernatant samples tested positive in 5 of 6 recurrence cases, indicating no obvious differences in the fraction used. Urine DNA was positive in 4 of the 13 nonrecurrence cases, among which three tested negative following Bacille Calmette‐Guerin therapy.

Conclusions

Urine DNA as screened by our genomic panel may be useful for predicting and detecting intravesical recurrence in UBC. The simultaneous evaluation of urine precipitation and supernatant may enhance the clinical utility of urine DNA during surveillance for intravesical recurrence in UBC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsNeoplasm Recurrence, LocalCarcinoma, Transitional CellBiomarkers, TumorDNA, NeoplasmHumansMaleAgedFemalePilot ProjectsMiddle AgedCystoscopyRetrospective StudiesAged, 80 and overProspective StudiesPredictive Value of TestsUrinary BladderFollow-Up StudiesCystectomy

Stichwörter der Autor:innen

intravesical recurrenceurine DNAurine cytologyurothelial bladder cancer

Substanzen

Biomarkers, TumorDNA, Neoplasm

Autor:innen und Institutionen

  • Department of Urology, Shinshu University School of Medicine, Nagano, Japan.
  • Department of Urology, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.
  • Genomic Analysis Center, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.
  • Department of Pathology, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.
  • Department of Gastroenterology, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.
  • The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Masashi Shiozaki, Tomonori Minagawa, Yosuke Hirotsu, Masao Omata, Yoshiyuki Akiyama

Förderung

  • This study was supported by a Grant-in-Aid for the Genome Research Project from Yamanashi Prefecture (to M.O. and Y.H.), the Japan Society for the Promotion of…

Zitieren

APA

Shiozaki, M., Minagawa, T., Yokoyama, H., Hirotsu, Y., Oyama, T., Omata, M., & Akiyama, Y. (2026). Prediction of Postoperative Intravesical Recurrence Using Urine DNA Monitoring in Nonmuscular‐Invasive Urothelial Bladder Cancer. International Journal of Urology. https://doi.org/10.1111/iju.70293

Vancouver

Shiozaki M, Minagawa T, Yokoyama H, Hirotsu Y, Oyama T, Omata M, et al. Prediction of Postoperative Intravesical Recurrence Using Urine DNA Monitoring in Nonmuscular‐Invasive Urothelial Bladder Cancer. International Journal of Urology. 2026. doi:10.1111/iju.70293

BibTeX
@article{Shiozaki2026,
  author = {Shiozaki, Masashi and Minagawa, Tomonori and Yokoyama, Hitoshi and Hirotsu, Yosuke and Oyama, Toshio and Omata, Masao and Akiyama, Yoshiyuki},
  title = {Prediction of Postoperative Intravesical Recurrence Using Urine DNA Monitoring in Nonmuscular‐Invasive Urothelial Bladder Cancer},
  journal = {International Journal of Urology},
  year = {2026},
  doi = {10.1111/iju.70293}
}
Kostenlos starten →